Developer docs
API playgroundTry for free, no card

Search company profiles

Bruschettini

Full company profile

uuid000hhet

Namestring
Bruschettini
Company typeenum
Private
Founded yearint
1910
Descriptiontext

Bruschettini is a privately held Italian pharmaceutical and medical-device manufacturer founded in 1910 and headquartered in Genova, Italy. According to the firmographic record, the company develops and manufactures products across three therapeutic categories — respiratory, primary care, and ophthalmic pharmaceuticals — alongside medical devices, an unusually diversified mix for a 110-year-old mid-cap Italian specialty manufacturer. With 101–250 employees, Bruschettini sits in the small-to-mid-cap tier of Italian pharmaceutical producers, a size class that is rare for a firm with this much operating history and that implies either a durable niche positioning or gradual scope-differentiation over the long corporate lifespan.

Short descriptiontext

Bruschettini is an Italian private pharmaceutical and medical-device company, founded in 1910 in Genova, that develops and manufactures respiratory, primary care, and ophthalmic pharmaceutical products for the Italian and adjacent European markets.

Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersGenova, Italy
HQ citystring
Genova
HQ countrystring
Italy
HQ regionstring
Europe
Markets served

Serves global market

Keyword5 values
pharmaceutical manufacturing, ophthalmic medications, respiratory therapeutics, medical device products, primary care pharmaceuticals
Industry4 codes
PRIMARYHLAIAAAH
Respiratory & Allergy Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals
SECONDARYHLAIAAAA
Primary Care & General Medicine Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals
SECONDARYHLAIACAK
Ophthalmology Specialty Pharmaceuticals
SECONDARYHLAIAAAB
Specialty Care Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals
NAICS code3 codes
  • Pharmaceutical Preparation Manufacturing325412
  • Surgical and Medical Instrument Manufacturing339112
  • Pharmaceutical and Medicine Manufacturing3254
SIC code2 codes
  • Pharmaceutical Preparations2834
  • Surgical & Medical Instruments & Apparatus3841
Product category
Pharmaceutical & Medical Device Manufacturing
No data
Cost components6 values
Operations, Personnel, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Bruschettini develops and manufactures pharmaceutical products in three therapeutic areas — respiratory, primary care, and ophthalmology — alongside a portfolio of medical devices. The company operates as a traditional pharmaceutical and medical-device producer headquartered in Genova, Italy, with a heritage dating to 1910. Its business centers on formulating, producing, and bringing to market finished drug products and physical medical devices for healthcare providers and patients.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

No product or service details are available from the provided source content. The website displays only a logo and loading state without any product descriptions, features, or named offerings.

Product and service1 record
1Respiratory pharmaceutical products
No data
Peers10 records
TypeDirect peer
Description

Italian privately-held specialty pharma headquartered in Parma with a strong respiratory franchise and growing ophthalmology and rare disease presence — directly comparable to Bruschettini on therapeutic focus, Italian mid-sized private status, and respiratory leadership.

TypeDirect peer
Description

Milan-based specialty pharma with established operations across multiple European therapeutic areas including ophthalmology and primary care — comparable to Bruschettini in being an Italian, multi-therapeutic specialty pharma with international reach.

TypeDirect peer
Description

Privately-held Italian pharmaceutical group with respiratory and CNS specialty pharma operations — directly comparable to Bruschettini in scale, Italian private ownership, and respiratory therapeutic focus.

TypeDirect peer
Description

Italian biopharmaceutical company developing specialty therapeutics across ophthalmology and primary care — comparable to Bruschettini on therapeutic verticals, mid-sized private European specialty pharma profile, and ophthalmology positioning.

TypeBroad incumbent
Description

Privately-held Italian pharma group operating across primary care, specialty care, and consumer health — comparable to Bruschettini in Italian private ownership and primary-care pharmaceutical focus, though larger and more diversified.

6Santen Pharmaceutical
TypeDirect peer
Description

Specialty pharma focused exclusively on ophthalmology with European commercial operations — directly comparable to Bruschettini's ophthalmic pharmaceutical business, both serving eye-care specialists with prescription therapeutics.

TypeBroad incumbent
Description

Global ophthalmology-focused pharmaceutical and medical device company — comparable to Bruschettini's ophthalmic pharmaceutical and medical device offerings, though operating at significantly larger scale and broader geographic reach.

TypeBroad incumbent
Description

Largest privately-held Italian pharmaceutical group with diversified portfolio spanning primary care, specialty, and diagnostics — comparable to Bruschettini on Italian private ownership and primary-care focus, but substantially larger and more internationally diversified.

TypeDirect peer
Description

European specialty pharma headquartered in Spain with strong dermatology and respiratory franchises — comparable to Bruschettini on European mid-sized specialty pharma profile and respiratory therapeutic focus.

TypeEmerging player
Description

Swiss-based specialty pharma with portfolio spanning ophthalmology, reproductive medicine, and primary care — comparable to Bruschettini on mid-sized European specialty pharma profile and ophthalmic pharmaceutical focus, though with a different geographic base.

Market position
Strengths3 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights4 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Bruschettini

Pharmaceutical & Medical Device Manufacturingbruschettini.com

Bruschettini is an Italian private pharmaceutical and medical-device company, founded in 1910 in Genova, that develops and manufactures respiratory, primary care, and ophthalmic pharmaceutical products for the Italian and adjacent European markets.

What Bruschettini does

Bruschettini is a privately held Italian pharmaceutical and medical-device manufacturer founded in 1910 and headquartered in Genova, Italy. According to the firmographic record, the company develops and manufactures products across three therapeutic categories — respiratory, primary care, and ophthalmic pharmaceuticals — alongside medical devices, an unusually diversified mix for a 110-year-old mid-cap Italian specialty manufacturer. With 101–250 employees, Bruschettini sits in the small-to-mid-cap tier of Italian pharmaceutical producers, a size class that is rare for a firm with this much operating history and that implies either a durable niche positioning or gradual scope-differentiation over the long corporate lifespan.

Bruschettini firmographics

Firmographics
Name
Bruschettini
Website
https://bruschettini.com
Company type
Private
Founded year
1910
Headcount range
101–250 employees
Short description
Bruschettini is an Italian private pharmaceutical and medical-device company, founded in 1910 in Genova, that develops and manufactures respiratory, primary care, and ophthalmic pharmaceutical products for the Italian and adjacent European markets.
Ownership category
akta.pro rank

Bruschettini industry classification

Industry
Product category
Pharmaceutical & Medical Device Manufacturing
NAICS
Pharmaceutical Preparation Manufacturing (325412), Surgical and Medical Instrument Manufacturing (339112), Pharmaceutical and Medicine Manufacturing (3254)
SIC
Pharmaceutical Preparations (2834), Surgical & Medical Instruments & Apparatus (3841)
akta.pro industry
PRIMARYHLAIAAAH
Respiratory & Allergy Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals
SECONDARYHLAIAAAA
Primary Care & General Medicine Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals
SECONDARYHLAIACAK
Ophthalmology Specialty Pharmaceuticals
SECONDARYHLAIAAAB
Specialty Care Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals

Keywords

  • Pharmaceutical manufacturing
  • Ophthalmic medications
  • Respiratory therapeutics
  • Medical device products
  • Primary care pharmaceuticals

Where Bruschettini is headquartered

Location

Headquarters

HQ city
Genova
HQ country
Italy
HQ region
Europe

Markets served

Bruschettini business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Operations, Personnel, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure

Bruschettini product offering

Product offering

Core offering

Bruschettini develops and manufactures pharmaceutical products in three therapeutic areas — respiratory, primary care, and ophthalmology — alongside a portfolio of medical devices. The company operates as a traditional pharmaceutical and medical-device producer headquartered in Genova, Italy, with a heritage dating to 1910. Its business centers on formulating, producing, and bringing to market finished drug products and physical medical devices for healthcare providers and patients.

Product overview

No product or service details are available from the provided source content. The website displays only a logo and loading state without any product descriptions, features, or named offerings.

Differentiator

Problem solved

Functional benefit

Products and services

  • Respiratory pharmaceutical products

Companies that use Bruschettini

Customer profile

Ideal customer profiles3 records

Bruschettini technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Bruschettini competitors and assessment

Company assessment

Direct peers

  • Chiesi Farmaceutici: Italian privately-held specialty pharma headquartered in Parma with a strong respiratory franchise and growing ophthalmology and rare disease presence — directly comparable to Bruschettini on therapeutic focus, Italian mid-sized private status, and respiratory leadership.
  • Recordati: Milan-based specialty pharma with established operations across multiple European therapeutic areas including ophthalmology and primary care — comparable to Bruschettini in being an Italian, multi-therapeutic specialty pharma with international reach.
  • Zambon: Privately-held Italian pharmaceutical group with respiratory and CNS specialty pharma operations — directly comparable to Bruschettini in scale, Italian private ownership, and respiratory therapeutic focus.
  • Dompé: Italian biopharmaceutical company developing specialty therapeutics across ophthalmology and primary care — comparable to Bruschettini on therapeutic verticals, mid-sized private European specialty pharma profile, and ophthalmology positioning.
  • Santen Pharmaceutical: Specialty pharma focused exclusively on ophthalmology with European commercial operations — directly comparable to Bruschettini's ophthalmic pharmaceutical business, both serving eye-care specialists with prescription therapeutics.
  • Almirall: European specialty pharma headquartered in Spain with strong dermatology and respiratory franchises — comparable to Bruschettini on European mid-sized specialty pharma profile and respiratory therapeutic focus.

Broad incumbents

  • Angelini Pharma: Privately-held Italian pharma group operating across primary care, specialty care, and consumer health — comparable to Bruschettini in Italian private ownership and primary-care pharmaceutical focus, though larger and more diversified.
  • Bausch + Lomb: Global ophthalmology-focused pharmaceutical and medical device company — comparable to Bruschettini's ophthalmic pharmaceutical and medical device offerings, though operating at significantly larger scale and broader geographic reach.
  • Menarini: Largest privately-held Italian pharmaceutical group with diversified portfolio spanning primary care, specialty, and diagnostics — comparable to Bruschettini on Italian private ownership and primary-care focus, but substantially larger and more internationally diversified.

Emerging players

  • IBSA Institut Biochimique: Swiss-based specialty pharma with portfolio spanning ophthalmology, reproductive medicine, and primary care — comparable to Bruschettini on mid-sized European specialty pharma profile and ophthalmic pharmaceutical focus, though with a different geographic base.

Market position

Strengths3 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights4 records

Customer concentration

Bruschettini financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Bruschettini leadership team

Management profile

Number of profiles

Bruschettini funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Bruschettini M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Bruschettini

What does Bruschettini do?

Bruschettini develops and manufactures pharmaceutical products in three therapeutic areas — respiratory, primary care, and ophthalmology — alongside a portfolio of medical devices. The company operates as a traditional pharmaceutical and medical-device producer headquartered in Genova, Italy, with a heritage dating to 1910. Its business centers on formulating, producing, and bringing to market finished drug products and physical medical devices for healthcare providers and patients.

When was Bruschettini founded?

Bruschettini was founded in 1910. It employs 101 to 250 people.

Where is Bruschettini based?

Bruschettini is headquartered in Genova, Italy, in the Europe region.

Who are Bruschettini's main competitors?

Direct peers on record are Chiesi Farmaceutici, Recordati, Zambon, Dompé, Santen Pharmaceutical and Almirall. Broad incumbents are Angelini Pharma, Bausch + Lomb and Menarini. IBSA Institut Biochimique is listed as an emerging player.

Does Bruschettini have an API?

No public API is recorded for Bruschettini.

What industry is Bruschettini in?

Bruschettini's product category is Pharmaceutical & Medical Device Manufacturing. Its primary akta.pro industry code is HLAIAAAH, Respiratory & Allergy Pharmaceuticals, with a secondary code of HLAIAAAA, Primary Care & General Medicine Pharmaceuticals. Its NAICS code is 325412 and its SIC code is 2834.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales